Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies (Details)

v3.25.1
Significant Accounting Policies (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Jan. 01, 2025
shares
Mar. 17, 2015
Mar. 31, 2025
segment
shares
Mar. 31, 2024
segment
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Significant Accounting Policies            
Number of reportable segments | segment     1 1    
Fortress Biotech, Inc            
Significant Accounting Policies            
Percentage of shares issued for offering and annual equity fee 2.50%          
Number of shares issued and sold 2,386,808   18,500 193,905    
Related Party | Fortress Biotech, Inc            
Significant Accounting Policies            
Percentage of shares issued for offering and annual equity fee 2.50% 2.50%        
Number of shares issued and sold 2,386,808          
Non-cash research and development expenses | $         $ 7.6 $ 3.4